Other research analysts have also recently issued reports about the stock. Zacks Investment Research cut shares of Udg Healthcare from a “buy” rating to a “hold” rating in a research note on Thursday, March 14th. Barclays raised shares of Udg Healthcare from an “equal weight” rating to an “overweight” rating in a research note on Thursday, April 4th.
Shares of UDHCF traded up $0.25 during mid-day trading on Tuesday, hitting $8.35. 1,000 shares of the company’s stock were exchanged, compared to its average volume of 10,009. Udg Healthcare has a 52 week low of $7.25 and a 52 week high of $12.95.
UDG Healthcare plc, together with its subsidiaries, provides advisory, communication, commercial, clinical, and packaging services in the Republic of Ireland, the United Kingdom, North America, and internationally. The company operates in two segments, Ashfield and Sharp. The Ashfield segment offers commercialization services for the pharmaceutical and healthcare industry in the areas of advisory, communications, and commercial and clinical services.
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Udg Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Udg Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.